Pulse Biosciences, Inc. (PLSE) stock
PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$44.84−1.52 (-3.28%)
Close on Nov 17, 2026Market cap $3.20BP/E –Yield –
Pulse Biosciences total assets
Total assets on the balance sheet at the end of each period.
Pulse Biosciences's total assets was $115.56M at Jun 30, 2026. For fiscal 2025 it was $94.54M, down 28.6% from the year before. Over ten years it grew 20.8% a year on average. The highest annual figure on record is $132.46M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $94.54M | -28.6% |
| FY2024 | Dec 31, 2024 | $132.46M | +123.9% |
| FY2023 | Dec 31, 2023 | $59.15M | -24.0% |
| FY2022 | Dec 31, 2022 | $77.88M | +31.7% |
| FY2021 | Dec 31, 2021 | $59.15M | +43.3% |
| FY2020 | Dec 31, 2020 | $41.29M | -1.5% |
| FY2019 | Dec 31, 2019 | $41.92M | -40.7% |
| FY2018 | Dec 31, 2018 | $70.64M | +41.8% |
| FY2017 | Dec 31, 2017 | $49.82M | +89.3% |
| FY2016 | Dec 31, 2016 | $26.31M | +83.7% |
| FY2015 | Dec 31, 2015 | $14.33M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $115.56M | -3.9% |
| Q1 FY2026 | Mar 31, 2026 | $81.62M | -38.8% |
| Q4 FY2025 | Dec 31, 2025 | $94.54M | -28.6% |
| Q3 FY2025 | Sep 30, 2025 | $108.77M | +16.9% |
| Q2 FY2025 | Jun 30, 2025 | $120.25M | +197.4% |
| Q1 FY2025 | Mar 31, 2025 | $133.38M | +171.3% |
| Q4 FY2024 | Dec 31, 2024 | $132.46M | +123.9% |
| Q3 FY2024 | Sep 30, 2024 | $93.05M | +41.1% |
| Q2 FY2024 | Jun 30, 2024 | $40.43M | -45.9% |
| Q1 FY2024 | Mar 31, 2024 | $49.16M | -30.0% |
| Q4 FY2023 | Dec 31, 2023 | $59.15M | -24.0% |
| Q3 FY2023 | Sep 30, 2023 | $65.95M | -24.7% |
| Q2 FY2023 | Jun 30, 2023 | $74.76M | +84.1% |
| Q1 FY2023 | Mar 31, 2023 | $70.22M | +77.6% |
| Q4 FY2022 | Dec 31, 2022 | $77.88M | +31.7% |
| Q3 FY2022 | Sep 30, 2022 | $87.57M | +30.4% |
| Q2 FY2022 | Jun 30, 2022 | $40.60M | -49.3% |
| Q1 FY2022 | Mar 31, 2022 | $39.53M | -50.9% |
| Q4 FY2021 | Dec 31, 2021 | $59.15M | +43.3% |
| Q3 FY2021 | Sep 30, 2021 | $67.15M | +35.1% |
| Q2 FY2021 | Jun 30, 2021 | $80.04M | +37.1% |
| Q1 FY2021 | Mar 31, 2021 | $80.56M | +153.0% |
| Q4 FY2020 | Dec 31, 2020 | $41.29M | -1.5% |
| Q3 FY2020 | Sep 30, 2020 | $49.70M | +2.0% |
| Q2 FY2020 | Jun 30, 2020 | $58.38M | +2.4% |
| Q1 FY2020 | Mar 31, 2020 | $31.84M | -49.8% |
| Q4 FY2019 | Dec 31, 2019 | $41.92M | -40.7% |
| Q3 FY2019 | Sep 30, 2019 | $48.70M | +48.8% |
| Q2 FY2019 | Jun 30, 2019 | $57.03M | +44.3% |
| Q1 FY2019 | Mar 31, 2019 | $63.45M | +41.6% |
| Q4 FY2018 | Dec 31, 2018 | $70.64M | +41.8% |
| Q3 FY2018 | Sep 30, 2018 | $32.73M | -39.5% |
| Q2 FY2018 | Jun 30, 2018 | $39.53M | +41.4% |
| Q1 FY2018 | Mar 31, 2018 | $44.80M | +56.8% |
| Q4 FY2017 | Dec 31, 2017 | $49.82M | +89.3% |
| Q3 FY2017 | Sep 30, 2017 | $54.12M | +87.7% |
| Q2 FY2017 | Jun 30, 2017 | $27.95M | – |
| Q1 FY2017 | Mar 31, 2017 | $28.57M | – |
| Q4 FY2016 | Dec 31, 2016 | $26.31M | – |
| Q3 FY2016 | Sep 30, 2016 | $28.83M | – |
See a number that looks wrong?